13F COMBINATION REPORT
DC Funds, LP
Quarter ended Q1 2024 · Filed May 14, 2024 · Accession 0001398344-24-009524
Total Value
$10.3M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TSCAN THERAPEUTICS INC | TCRX | 630,000 | $5.0M | 48.34% |
| 2 | WEREWOLF THERAPEUTICS INC | HOWL | 589,102 | $3.8M | 36.89% |
| 3 | BARINTHUS BIOTHERAPEUTICS PL | BRNS | 642,204 | $1.5M | 14.77% |